Fresenius Medical Care AG & Co. KGaAFMSNYSE
Loading
R&D Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-11.6%
5Y CAGR-4.0%
Year-over-Year Change
Research and development spending
3Y CAGR
-11.6%/yr
vs +14.3%/yr prior
5Y CAGR
-4.0%/yr
Recent deceleration
Acceleration
-25.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $158.00M | -13.9% |
| 2024 | $183.49M | -20.9% |
| 2023 | $231.97M | +1.5% |
| 2022 | $228.62M | +3.6% |
| 2021 | $220.78M | +13.9% |
| 2020 | $193.77M | +15.3% |
| 2019 | $168.03M | +25.4% |
| 2018 | $134.00M | +2.3% |
| 2017 | $131.00M | -15.0% |
| 2016 | $154.04M | - |